Streetbeat News

Partnerships

HEPS

V

Hepsiburada (NASDAQ:HEPS), a leading Turkish e-commerce platform, has announced a five-year agreement with Visa (NYSE:V), a world leader in digital payments. The partnership will allow Hepsipay cards to bear the Visa logo and be accepted at any point of sale worldwide. This move expands the use of Hepsipay cards beyond the Hepsiburada platform.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 12:32 pm

ENPH

Enphase Energy, Inc. (NASDAQ:ENPH) has expanded its agreement with German-based climate tech startup 1KOMMA5° to enter the solar markets in Sweden and Denmark. The deal will see 1KOMMA5° offer Enphase's Energy Systems, powered by IQ8 Microinverters and IQ Batteries. The devices will be integrated into 1KOMMA5°'s proprietary energy IoT system, Heartbeat, and become part of their virtual power plant. The Enphase Energy System with IQ Batteries offers configurations ranging from 3.5kWh to an aggregate 42kWh and can be upgraded throughout the lifetime of the system.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 12:08 pm

NGMS

RSI

NeoGames S.A. (NASDAQ:NGMS) announced that its subsidiary Pariplay has entered Pennsylvania for the first time with Rush Street Interactive (NYSE:RSI). Pariplay's content went live on RSI brands BetRivers and PlaySugarHouse in Pennsylvania on September 29, 2023. This marks the fifth US state entered by Pariplay, which offers over 14,000 games from 120+ suppliers.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 12:07 pm

PATH

UiPath has announced a new integration service connector that will give its customers access to Amazon Bedrock. This move is expected to enhance the company's automation capabilities and expand its customer base.

Portfolio Pulse from Bill Haddad

October 09, 2023 | 12:06 pm

MREO

RARE

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) and Mereo BioPharma Group plc (NASDAQ:MREO) will present new data from the Phase 2/3 Orbit study of setrusumab in osteogenesis imperfecta (OI) at the American Society for Bone and Mineral Research 2023 Annual Meeting. The data includes updated results on annualized clinical fracture rate in patients aged 5 to <26 years, and data on the burden of fractures for individuals living with OI. The companies previously announced positive data from the dose-selection Phase 2 portion of the Orbit study showing that setrusumab rapidly induced bone production in OI-affected patients.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 12:04 pm

MLRT

MetAlert, Inc (OTC:MLRT) has received and delivered its first commercial order for the GunAlert firearm recovery device from Range USA. The device, developed by MetAlert's subsidiary Level 2 Security, uses motion detection and GPS technology to monitor unauthorized use and movement of firearms. The company plans to work with law enforcement and media to promote the technology.

Portfolio Pulse from Anusuya Lahiri

October 09, 2023 | 12:00 pm

BBY

Best Buy Co Inc (NYSE:BBY) will start selling the Dexcom G7 Continuous Glucose Monitoring System (CGM) online, marking its first foray into prescription-based medical devices. The sale will be facilitated by Wheel, a virtual care platform, and HealthDyne, a pharmacy technology provider. This move aligns with Best Buy Health's goal to facilitate care at home.

Portfolio Pulse from Shivani Kumaresan

October 09, 2023 | 11:54 am

MSFT

OpenAI's ChatGPT Vision, backed by Microsoft Corp. (NASDAQ:MSFT), is a new image analyzer tool that can perform a range of tasks such as generating code from a flow chart, understanding complex PowerPoint slides and memes, analyzing nutrition, translating manuscripts, and even finding Waldo. The tool can take screenshots from Figma and generate code, understand complex PowerPoint slides, provide art critiques, analyze nutrition in food items, translate manuscripts, decode complex movie outlines like Christopher Nolan's Inception, explain memes, and find Waldo in images.

Portfolio Pulse from Rounak Jain

October 09, 2023 | 11:52 am

DCGO

DocGo's UK-based subsidiary has been awarded a 5-year contract to provide emergency and urgent ambulance services for South Central Ambulance Service NHS Foundation Trust. The contract includes the provision of 16 ambulances per day for paramedic-led frontline urgent and emergency response. No financial terms were disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 11:37 am

CANF

Can-Fite BioPharma has signed an agreement with Fondazione Telethon for the co-development of Piclidenoson for Lowe Syndrome in Japan. Additional meetings with Japanese companies interested in Can-Fite's oncology and dermatology indications are also planned.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 11:20 am